Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
63.5 USD | -1.17% |
|
+3.35% | +15.16% |
Jul. 02 | ANI Pharmaceuticals Receives FDA Approval for Naproxen Delayed-Release Tablets | MT |
Jul. 02 | ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.16% | 1.23B | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+17.90% | 228B | |
+14.86% | 177B |
- Stock Market
- Equities
- ANIP Stock
- News ANI Pharmaceuticals, Inc.
- ANI Pharmaceuticals Launches Pentoxifylline Extended-Release Tablets